StevensonJC. HRT for the primary prevention of coronary heart disease. In: BrintonRGenazzaniASimonciniT, et al. (eds) Sex Steroids’ Effects on Brain, Heart and Vessels. ISGE Series. Cham: Springer2019: 257–264.
2.
BontempoSYeganehLGiriR, et al.Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis. Climacteric2024; 27(1): 93–103. DOI: 10.1080/13697137.2023.2273524.
3.
CherryNMcNameeRHeagertyA, et al.Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised trial. BJOG2014; 121: 700–705.
SchlipakMGAngejaBGGoAS, et al.Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation2001; 104: 2300–2309.
6.
HerringtonDMVittinghoffELinF, et al.Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin replacement study (HERS). Circulation2002; 105: 2962–2966.
7.
KremerCGdovinovaZBejotY, et al.European stroke organisation guidelines on stroke in women: management of menopause, pregnancy and postpartum. European Stroke Journal2022; 7(2): I–XIX. DOI: 10.1177/23969873221078696.
8.
ConnellyPJCurrieGDellesC. Sex differences in the prevalence, outcomes and management of hypertension. Curr Hypertens Rep2022; 24(6): 185–192. DOI: 10.1007/s11906-022-01183-8.
KimJEChangJHJeongMJ, et al.A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases. Sci Rep2020; 10(1): 20631. DOI: 10.1038/s41598-020-77534-9.
11.
ViscoliCMBrassLMKernanWN, et al.A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med2001; 345(17): 1243–1249. DOI: 10.1056/NEJMoa010534.
12.
AliMvan EttenESAkoudadS, et al.Haemorrhagic stroke and brain vascular malformations in women: risk factors and clinical features. Lancet Neurol2024; 23(6): 625–635. DOI: 10.1016/S1474-4422(24)00122-4.
13.
FeldmannEBroderickJPKernanWN, et al.Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke2005; 36(9): 1881–1885. DOI: 10.1161/01.STR.0000177480.62341.6b.
14.
RenouxCDell’anielloSGarbeE, et al.Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ2010; 340: c2519. DOI: 10.1136/bmj.c2519.
15.
BoardmanHMHartleyLEisingaA, et al.Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev2015; 2015(3): CD002229. DOI: 10.1002/14651858.CD002229.pub4.
16.
CarpenterJSShengYElombaC, et al.A systematic review of palpitations prevalence by menopausal status. Curr Obstet Gynecol Rep2021; 10: 7–13.
17.
ShengYCarpenterJSElombaCD, et al.Effect of menopausal symptom treatment options on palpitations. A Systematic Review Climacteric2022; 25(2): 128–140. DOI: 10.1080/13697137.2021.1948006.
18.
CostaSSagunerAMGasperettiA, et al.The link between sex hormones and susceptibility to cardiac arrhythmias: from molecular basis to clinical implications. Front. Cardiovasc. Med2021; 8: 644279. DOI: 10.3389/fcvm.2021.644279.
19.
LeeJKimYParkH, et al.Clinical impact of hormone replacement therapy on atrial fibrillation in postmenopausal women: a nationwide cohort study. J Clin Med2021; 10(23): 5497. DOI: 10.3390/jcm10235497.
20.
GaingKWFedchenkoMDellborgM, et al.Burden of ischemic stroke in patients with congenital heart disease: a nationwide, case-control study. J Am Heart Assoc2021; 10: e020939. DOI: 10.1161/JAHA.120.02093.
21.
NordmanIDFejzicZBosM, et al.Cardiac abnormalities in girls with Turner syndrome: ECG abnormalities, myocardial strain imaging, and karyotype–phenotype associations. Am J Med Genet2021; 185A: 2399–2408.
22.
GrouthierVMoeyMYYGandjbakhchE, et al.Sexual dimorphisms, anti-hormonal therapy and cardiac arrhythmias. Int J Mol Sci2021; 22: 1464. DOI: 10.3390/ijms22031464.
23.
NebeskiDBasicCSvanvikT, et al.SWED-PREG. Incidence of spontaneous coronary artery dissection during pregnancy in Swedish women between 1997 and 2019, a retrospective observational cohort study based on national Swedish health-registers. Eur Heart J2022; 43(2): ehac544–1172. DOI: 10.1093/eurheartj/ehac544.1172ehac544-1172.
24.
LindenfeldJGhaliJKKrause-SteinraufHJ, et al.Hormone replacement therapy is associated with improved survival in women with advanced heart failure. J Am Coll Cardiology2003; 42(7): 1238–1245. DOI: 10.1016/s0735-1097(03)00938-0.